AtkinsRéalis Group Inc.

Q1 2026 results showed strong momentum, with net income up 34.2% year-over-year, adjusted diluted EPS rising 27% to $0.80, and Adjusted EBITDA growing 18.4%. Management expressed confidence in achieving full-year 2026 financial targets, supported by a strengthening backlog and robust demand across segments.

Despite near-term results, longer-term earnings forecasts remain deeply concerning. Annual EPS is projected to decline at 23.5% per annum, and analysts estimate near-zero EPS for the next quarter, signaling that current profitability gains may not be sustainable over a multi-year horizon.

The Nuclear segment posted a quarterly record-high Segment Adjusted EBIT of $81.8 million in Q1 2026, up 30.6% year-over-year. BMO has noted the company is well-positioned to capture new-build nuclear opportunities, and an unexplained 13.6% stock surge in June 2026 has been linked to speculation around the company's 100-gigawatt nuclear target by 2047.

Despite excitement around nuclear growth, analysts at National Bank downgraded the stock to Sector Perform, stating that 'positives appear priced in.' This suggests that the nuclear opportunity may already be reflected in the current valuation, limiting further upside for new investors entering at current price levels.

The broad analyst consensus remains a Buy, with an average 12-month price target of C$115.00 — implying nearly 30% upside from the last close of C$88.73. Financhill's historical model further supports a 52-week price target of $105.65, citing a 74% historical accuracy rate for upward moves over a one-year period.

Several analysts have been actively cutting their price targets, with Stifel lowering its target to C$99.00, CIBC cutting to C$120 after Q1 results, and TD trimming to C$117. The stock has risen only 0.46% since the start of 2026, and the wide dispersion between the low target of C$104 and high of C$131 reflects significant uncertainty about fair value.